Meropenem Iv Infusion Generics - Manufacturers & Suppliers
Merrem (US & EU)
| Product/Composition:- | Meropenem IV infusion |
|---|---|
| Strength:- | 500 mg, 1 g, 2 g in vials |
| Form:- | Powder for Reconstitution |
| Reference Brands:- | Merrem (US & EU) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Meropenem IV inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to bacterial lysis. It offers broad-spectrum activity against resistant gram-negative and gram-positive bacteria, including Pseudomonas. Benefits include rapid, potent bactericidal effect, excellent tissue penetration, and use in critical infections, ensuring reliable, effective treatment in hospital settings.
Meropenem IV infusion is approved in the EU and US for severe bacterial infections including pneumonia, urinary tract infections, and intra-abdominal sepsis. In the EU, brands like Merrem are regulated by EMA with dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic options are available. Both regions require detailed dossiers including clinical trial results, quality assurance, and pharmacovigilance plans for approval and ongoing safety monitoring. Due to its critical role in combatting resistant bacteria, strict prescribing and monitoring guidelines are enforced. For expert help with regulatory dossiers, compliance, and registration, visit PharmaTradz. We enable seamless market access aligned with European and US standards.